45th Annual Veterinary
Orthopedic Society
Conference


March 10 - March 17, 2018 at
Snowmass Village, CO

Call for Abstracts


We invite practitioners, academicians, and researchers interested in large animal, small animal, and exotic species, to submit abstracts of novel studies in practical and scientific topics related to veterinary orthopedics and traumatology. Preference will be given to abstracts that have clinical relevance. Papers addressing results of controlled retrospective and prospective clinical studies are strongly encouraged. Clinician investigators should also consider submitting innovative surgical techniques, or case reports describing unusual or difficult cases as these will be reviewed separate from the scientific abstracts. Presentations will be limited to 10 minutes and followed by 5 minutes of discussion. Posters must fit within the 4' (height) x 4' (width) area provided.

Call for papers will open on August 15th 2017 and close on Sunday, October 15, 2017 for both podium presentations and posters. See the link on the VOS website: www.vosdvm.org for full details of abstract submission, formatting and regulations.

Submission categories are:

  1. Clinical Research / Basic Science Research

  2. Case Report / Series: a maximum of three novel or interesting cases

    The Mark S. Bloomberg Memorial Resident Research Award was established to recognize outstanding resident abstract submissions to the scientific program. At least one recipient per year will be awarded up to $1500.00 towards expenses to attend and present their abstract at our annual meeting. Only individuals currently in a residency training program or within 2 years of completion of a formal residency program are eligible. The abstract submission may only be of studies conducted during the residency program. All abstracts being submitted for consideration of this award must indicate so on online submission form.

Reunan Guillou, VOS Scientific Program Chair
Email address: reunanguillou@gmail.com

José M. García-López, VOS Assistant Scientific Program Chair
Email address: jose.garcia-lopez@tufts.edu


Submission Details

  1. Notes from the Program Chair

    There will only be one call for papers that requires a final, complete abstract be submitted by Sunday, October 15, 2017. NO subsequent changes to the abstract will be allowed. Please note that ONLY submissions that include BOTH the long and short versions of the abstract, PROPERLY FORMATTED, will be considered. Abstracts will be scored blinded based on the significance of the findings, originality, scientific quality and general interest. Case reports will be reviewed based on novelty, practical interest, and completeness.

  2. Deadline

    Abstract deadline: Sunday, October 15, 2017. Abstracts with complete data and statistical analysis, if applicable, must be received by this date.
  3. Submission Requirements


    PLEASE READ COMPLETELY BEFORE PREPARING AND SUBMITTING ABSTRACTS

      Submission requires the following information:

    • Category - Clinical Research, Basic Science Research, or Case Report/Series
      Clinical Research is patient oriented research. This includes using clinical patients or their tissues to study mechanisms of disease, interventions, complications, or epidemiological research.
      Basic Science Research is research into the mechanisms or treatment of disease using models (i.e. disease induction, biomechanical testing, etc).
      Case Report/Series is a single case or cases where the epidemiology, disease mechanism, or novel treatment is described along with outcome.

    • Session - Choose the most appropriate session from the list of themes. VOS may reallocate the presentation depending upon the number and nature of submissions.

    • Species - Large animal, small animal, or exotic.

    • Title: Should accurately reflect what was done. Please use Title Case.

    • Presentation preference (podium, poster, either). All those submitting for podium preference will also be considered for poster, but preference will be given to the podium presentation. Those who choose poster will not be considered for podium presentation.

    • Author - Author affiliation and contact information. Try to make affiliations as coordinated as possible, rather than having a different affiliation for each author at the same institution. Please add all co-authors and co-workers to avoid reviewer conflict of interest.

    • Disclosure - Acknowledgement section for funding source or any conflicts of interest.

    • Two abstracts - a short abstract for publication and a long abstract for the review process.

      • SHORT abstract: This abstract will be used for publication in VCOT and the Conference Proceedings and is limited to 250 words in Arial or Times-New Roman 12 pt formatting.This is the published abstract, so please ensure care with your language and grammar - despite the word limit.


      • LONG abstract: The abstract length is limited to 800 words (excluding references, tables and figures). Single space between paragraphs, using Times New Roman or Arial 12 pt font. Do NOT include authors’ names or affiliations in this abstract to maintain anonymity during the review process. VOS is not responsible if affiliations are included in this abstract. Pictures, tables, and figures are allowed.


      You should receive an email message within 24 hours of submission, confirming that submission materials were received, readable, and correctly formatted.
  4. Abstract Headings: Clinical Research / Basic Science Research

    The following headings are required for submission of Clinical Research and Basic Science Research Studies abstracts (for both long and short abstracts). Headings are not required for Case reports/Series, but proprietary or conflict of interest statement is still required.

    • INTRODUCTION: Background on general topic or previous work; include statement of purpose of the study and hypothesis. This should convey the need, significance/impact of the work.

    • MATERIALS & METHODS: Briefly describe the methodology of research or technique used in this study. Methods should be appropriate to answer the hypothesis or problem that generated the work.

    • RESULTS: Data should be presented in sufficient detail to support the conclusions. It is not acceptable to generalize or state, "results will be discussed".

    • DISCUSSION/CONCLUSION: Include an interpretation of the results. Do not simply restate the results. Was the hypothesis/problem answered? Were limitations or additional problems identified? How can the information derived from this study, or technique, best be applied to further research or clinical situation? Provide relevance and/or innovation to the current body of knowledge.

    • REFERENCES: A limited number (e.g. five) of references are allowed, if necessary, in the long abstract.

    • ACKNOWLEDGMENT: Disclose any proprietary interest and identify financial support, either by direct funding (extramural or intramural) or materials. This MUST be provided in both the short and long abstracts for the abstracts to be considered complete. If there is no funding, you must still make a statement like "There was no proprietary interest or funding provided for this project."
  5. Humane Care and Use of Animals


    Authors are required to certify that the study submitted was conducted in a manner consistent with the U.S. National Institutes of Health "Guide for the Care and Use of Laboratory Animals" (http://grants.nih.gov/grants/olaw/olaw.htm), the Animal Welfare Acts (US PL 89-544;91-579;94-279), and the Guide for the Care and Use of Agricultural Animals in Agricultural Research and Teaching (http://www.fass.org/page.asp?pageID=216), including appropriate methods of euthanasia (American Veterinary Medical Association Guidelines for the Euthanasia of Animals; http://grants.nih.gov/grants/olaw/olaw.htm) Regulations governing experimental animal use in some countries are more stringent than those in the US, and where this is the case, authors from those countries are cautioned to ensure that their studies meet the requirements of the country in which the study was conducted. For all other countries, the minimum standard for abstract consideration is compliance with US regulations. Inappropriate experimental use of animals or inadequate anesthesia and analgesia, including postoperative analgesia, will preclude further consideration.

Begin a submission to the following:

CASE REPORT / SERIES

CLINICAL RESEARCH / BASIC SCIENCE RESEARCH

Deadline for ALL New Submissions: Sunday, October 15, 2017 at 11:59 pm HAST (Hawaii-Aleutian Time Zone).

Podium presentations at the Conference:

     PowerPoint and Keynote(single screen) will be the only podium presentation mediums guaranteed at the Conference. If any other audiovisual aid is required, please inform the program chair(s) at least 30 days in advance. ALL presentations will use the VOS computer designated for this purpose. ALL presentation files MUST be loaded on the designated computer at least one session prior to scheduled presentations. Failure to do so will result in elimination of the presentation from the Conference. ALL presentations will be limited to a maximum of 10 minutes. Moderators will strictly enforce the 10-minute time limit.

Poster presentations at the Conference:

Posters must fit within the 4’ (height) x 4’ (width) area provided at the Conference. Poster presenters are responsible for bringing materials (push pins, tape, etc.) required for mounting the posters for display. The posters should be posted for display on Sunday and removed by noon on Thursday. Presenting authors must attend and be available to answer questions during the entire dedicated Poster Session if they wish to have their poster scored for awards.

Technical Support

For help in submitting an abstract online, Contact technical support